Trial Outcomes & Findings for Hepatitis C Testing in VA Community-Based Outpatient Clinics (NCT NCT02936648)
NCT ID: NCT02936648
Last Updated: 2018-11-20
Results Overview
Number of Participants with HCV Antibody Test
Recruitment status
COMPLETED
Study phase
NA
Target enrollment
2209 participants
Primary outcome timeframe
within 30 days of outpatient primary care visit
Results posted on
2018-11-20
Participant Flow
Participant milestones
| Measure |
Quality Improvement Intervention
quality improvement Intervention
quality improvement : HCV Testing quality improvement
|
|---|---|
|
Overall Study
STARTED
|
2209
|
|
Overall Study
COMPLETED
|
2209
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Hepatitis C Testing in VA Community-Based Outpatient Clinics
Baseline characteristics by cohort
| Measure |
Baseline Characteristics at Intervention Sites
n=2209 Participants
QI Intervention. QI: HCV Testing QI. Baseline characteristics at intervention sites, pre-implementation.
|
|---|---|
|
Age, Customized
Age · <60
|
505 Participants
n=5 Participants
|
|
Age, Customized
Age · >60
|
1704 Participants
n=5 Participants
|
|
Sex: Female, Male
Female
|
136 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
2073 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
29 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
1526 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
654 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
56 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
1470 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
683 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: within 30 days of outpatient primary care visitNumber of Participants with HCV Antibody Test
Outcome measures
| Measure |
Quality Improvement Intervention
n=2209 Participants
QI Intervention
QI: HCV Testing QI
|
|---|---|
|
HCV Antibody Test
|
574 Participants
|
Adverse Events
HCV Testing QI
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Vera Yakovchenko
Department of Veterans Affairs, CHOIR and BridgeQUERI
Phone: 781.687.3374
Email: [email protected]
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place